Emily Shacter
Division of Therapeutic Proteins
CBER, FDA, Rockville
Maryland 20852
USA
Name/email consistency: high
- Re-processing of biological products: regulatory considerations from the CBER perspective. Shacter, E. Dev. Biol. (Basel) (2003)
- Chronic inflammation and cancer. Shacter, E., Weitzman, S.A. Oncology (Williston Park, N.Y.) (2002)
- Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis. Shacter, E., Williams, J.A., Hinson, R.M., Sentürker, S., Lee, Y.J. Blood (2000)